Study the CAADC content as a single clinical chain: assessment findings determine care intensity, care intensity shapes the written plan, the plan drives each progress note, and confidentiality rules govern what leaves the record. Practice with one running case vignette that you push through every domain, then check your work against a rubric rather than rereading summaries.
Rating DSM-5 severity without mixing it up with placement
Severity is a diagnostic rating based on the count of met criteria in a period; placement is a separate decision about care intensity. Learn both, and practice keeping them distinct.
The DSM-5 substance use disorder diagnosis rests on eleven criteria grouped in four clusters: impaired control, social impairment, risky use, and pharmacological features (tolerance and withdrawal). Meeting two or three criteria in twelve months yields a mild rating, four or five moderate, six or more severe. Remission specifiers attach to the diagnosis when criteria have not been met for three months (early) or twelve months (sustained). Drill the eleven criteria until you can classify a vignette statement as criterion-based evidence or background detail.
The common confusion to train against is treating 'severe' as a synonym for 'needs inpatient care.' A person can meet six criteria and still function in outpatient treatment, and a person with a mild rating can have a medical complication that changes the care decision. Severity is one input to placement, filtered through additional dimensions covered below. When you write practice answers, name the rating, cite which criteria you counted, and stop — do not let the diagnosis silently become the level-of-care conclusion.
Turning assessment data into a defensible level-of-care match
Multidimensional placement frameworks, such as the ASAM Criteria, match care intensity to risk across six dimensions rather than to diagnosis alone or client preference alone.
Frameworks like the ASAM Criteria organize the placement decision around dimensions covering acute intoxication and withdrawal risk, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and the recovery environment. A defensible match explains which dimension drives the intensity: withdrawal risk and biomedical instability push toward more structured care, while a supportive environment and strong readiness can justify less restrictive settings. Practice summarizing a vignette in one line per dimension before you name a level of care.
Worked scenario: a client with severe alcohol use disorder reports tremors and sweating each morning, lives with a supportive spouse, and says he wants to quit 'cold turkey at home.' A plausible mistake is honoring the home plan because motivation and family support look strong. The better decision is to weigh the withdrawal dimension first: a history of morning tremors and sweating suggests risk of a complicated alcohol withdrawal that outpatient support cannot monitor, so a medically monitored withdrawal management setting is the more defensible match, with outpatient care to follow. Why it matters: the two most persuasive features in the vignette point the wrong way, which is exactly how placement reasoning fails under time pressure.
- Write one sentence per placement dimension before naming any level of care.
- Circle every withdrawal or biomedical cue in a vignette before reading the rest.
- State which dimension is driving the intensity decision, in writing.
Writing goals and objectives an assessor could actually verify
A goal states the broad intended outcome; an objective states the observable behavior, target, and timeframe that show progress toward it. Plans must trace back to assessment findings.
A well-formed treatment plan reads like an argument from evidence to action. Each problem statement should paraphrase specific assessment data ('client reports three DUIs in five years' rather than 'legal issues'), each goal should name the intended change in that problem, and each objective should be measurable — who does what, how often, by when, and how it will be observed. Vague objectives like 'client will understand triggers' cannot be marked met or unmet; 'client will name three personal high-risk situations and one coping response for each in session by week four' can.
Worked scenario: an assessment notes opioid use, stable housing, ambivalence about stopping, and no medical complications. A plausible mistake is writing a plan built around residential treatment goals — structure, daily groups, supervised housing — that the assessment never justified. The better decision is to plan for the actual level of care: an intensive outpatient objective such as attending three groups weekly for eight weeks, plus one objective targeting ambivalence, such as completing a decisional balance exercise by session three. Why it matters: a plan mismatched to placement creates objectives the client cannot pursue and documentation that contradicts itself at every progress note.
Sorting pharmacology by mechanism class instead of drug by drug
Group medications into agonist, partial agonist, and antagonist classes, and pair each withdrawal syndrome with its characteristic risk profile. Classes are easier to retain and reason with than isolated drug facts.
For opioid use disorder, the three classes matter because they act differently: full agonists such as methadone activate the receptor fully, the partial agonist buprenorphine has a ceiling effect that limits respiratory depression, and the antagonist naltrexone blocks receptor activation entirely and requires a period of abstinence from opioids before initiation. For alcohol use disorder, disulfiram produces an unpleasant reaction if alcohol is consumed, naltrexone blunts rewarding effects, and acamprosate is thought to ease prolonged withdrawal symptoms. Know what each class does, not just the drug name.
Withdrawal is the second half of this domain, and the pairing to internalize is that alcohol, benzodiazepine, and other sedative withdrawal can be medically dangerous — with possible seizures and delirium — while opioid withdrawal, though severely uncomfortable, is typically not life-threatening on its own. Stimulant withdrawal centers on crash symptoms such as fatigue and depressed mood. When a vignette mentions sedative use with abrupt cessation, treat it as a medical monitoring question first; when it mentions opioid cessation, treat comfort and relapse risk as the leading concerns.
| Medication | Class | Primary use and key reasoning point |
|---|---|---|
| Methadone | Full opioid agonist | Opioid use disorder; dispensed in regulated settings, full receptor activation |
| Buprenorphine | Partial opioid agonist | Opioid use disorder; ceiling effect limits overdose risk relative to full agonists |
| Naltrexone | Opioid antagonist | Opioid use disorder; blocks effects, requires opioid-free interval before starting |
| Acamprosate | Mechanism thought to ease prolonged withdrawal | Alcohol use disorder; supports abstinence maintenance |
| Disulfiram | Aversion-based agent | Alcohol use disorder; produces unpleasant reaction with alcohol consumption, needs informed consent |
Applying 42 CFR Part 2 and HIPAA to a disclosure request
Federal confidentiality rules for substance use disorder treatment records are stricter than general health privacy rules; identify whether they apply before responding to any request for client information.
Two named frameworks govern most confidentiality questions in this field. HIPAA sets baseline privacy protections for health information generally. 42 CFR Part 2 adds a stricter layer for records from federally assisted substance use disorder treatment programs, restricting redisclosure and requiring consent content that specifically identifies the disclosing program, the recipient, and the purpose. The first step in any disclosure question is classifying the record: general health information follows HIPAA logic, while Part 2-covered records cannot simply ride along on a broader release.
Worked scenario: a client in your program signs a general medical records release, and her probation officer later calls asking for confirmation of attendance and her diagnosis. A plausible mistake is treating the signed release as permission and reading the diagnosis over the phone. The better decision is to check whether the release satisfies Part 2 requirements — naming the program, the recipient, and the scope of information — and to disclose only what a compliant consent or a specific legal authority covers, then document what was released and under what basis. Why it matters: general releases frequently fail Part 2's specificity requirements, and the caller's authority does not substitute for a valid consent.
- Classify every record first: ordinary health information or Part 2-covered program record.
- Check consent elements before phone disclosures, even with a release on file.
- Document the legal basis for each disclosure at the time it happens.
Coordinating referrals so the handoff actually completes
Case management depends on distinguishing making a referral from completing one: confirmation of contact, service receipt, and follow-up on barriers.
A referral is finished when the counselor confirms the client connected and received the service — not when a phone number is handed over. Strong case management practice distinguishes a cold referral (information given), a warm handoff (the counselor facilitates direct contact), and follow-up (checking whether the connection occurred and what barriers appeared). Match the referral method to the client's situation: a client with low readiness or transportation barriers needs more facilitation than a phone number, and the plan should say so.
Practice reading vignettes for the coordination cues: co-occurring mental health symptoms point to referral and communication with a prescribing or therapy provider; legal involvement calls for coordination with supervision requirements within confidentiality limits; medical findings call for a primary care or specialty referral and a release that lets providers exchange what is needed. In each case, the defensible answer identifies the referral target, the method, the consent basis for sharing information, and the follow-up step that verifies the loop closed.
Making notes, records, and a study sequence that test the whole chain
Progress notes should reference the plan, record observable evidence, and support the next decision. Build one running vignette through all domains as your core practice exercise.
Documentation ties the chain together. A defensible progress note names the objective it addresses, describes what the counselor observed and what the client reported in observable terms, records interventions delivered, and states the plan for the next contact. Practice rewriting vague sentences — 'client did well in group today' becomes 'client identified two high-risk situations and role-played a refusal response; will practice the same skill at home and report at next session.' Every note should let a reader reconstruct what happened and why the plan is or is not on track.
Practical exercise with a self-check rubric: take one written vignette and, over a week, produce (1) a severity rating citing the criteria counted, (2) a one-line-per-dimension placement rationale, (3) one goal with two measurable objectives, (4) one disclosure decision with its legal basis, and (5) a progress note tied to an objective. Score each item: 2 points if a peer could reconstruct your reasoning without asking questions, 1 point if partly clear, 0 if they could not. A consistent 8 or higher across two different vignettes suggests the chain is holding; a lower score tells you which link to restudy. Adapt the sequence by rotating a fresh vignette weekly, weighting whichever domain scored lowest, and rehearsing the disclosure decision under a short timer so the classification step stays deliberate under time pressure.
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.